.Pharmacolibrary.Drugs.ATC.L.L03AA14

Information

name:Lipegfilgrastim
ATC code:L03AA14
route:subcutaneous
compartments:2
dosage:6mg
volume of distribution:67L
clearance:0.1liter/hour
other parameters in model implementation

Lipegfilgrastim is a long-acting, glycoPEGylated recombinant human granulocyte colony-stimulating factor (G-CSF) analogue. It is used to reduce the duration of neutropenia and the incidence of febrile neutropenia in adult patients undergoing cytotoxic chemotherapy. It is an approved drug in Europe, marketed mainly under the trade name Lonquex.

Pharmacokinetics

Pharmacokinetic parameters in adult cancer patients, both male and female, after a single subcutaneous dose of 6 mg lipegfilgrastim following cytotoxic chemotherapy.

References

    Revisions


    Generated at 2025-08-11T18:21:04Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos